drugset / Trial / NCT04831502
Bioavailability and Food Effect Study of Two Formulations of TAK-906
RandomizedCrossoverOpen-labelOther
Summary
The aim of this study is to understand how TAK-906 tablets and capsules are processed by the body in healthy adults under fasting conditions and also how TAK-906 tablets are processed by the body when taken with a high fat high calorie breakfast compared to fasting. This study will require participants to stay at the clinical research unit for about 3 weeks to be monitored after receiving TAK-906.
Timeline
- Start
- 2021-04-02
- Primary completion
- 2022-02-02
- Completion
- 2022-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trazpiroben | Small molecule | 50 mg | Oral |
Indications
No indication recorded.